Tranquil

Funding the Future of

Mental Health Access

1 in 5

U.S. adults experience mental illness

~1,000

Clinics serve 40M+ people needing treatment

60%+

TMS remission rates

About Tranquil Health

Tranquil Health is building nationwide access to TMS therapy by funding modern clinics, proven revenue models, and a mission-driven team.

Our experienced leadership team combines healthcare expertise with proven business success through our operating partner, positioning us to revolutionize mental health treatment accessibility across the United States.

Conditions Treated By Partner Clinics

TMS therapy has been proven effective for a wide range of mental health and neurological conditions.

  • Smoking Addiction

    Helps reduce cravings and support cessation. FDA-approved for treatment.

  • PTSD

    Reduces trauma-related symptoms and anxiety. EU-approved for treatment.

  • Anxiety

    Alleviates anxiety disorders and panic symptoms. EU-approved for treatment.

  • Migraines

    EU-approved for migraine prevention and treatment.

  • Parkinson's

    Helps with motor symptoms & depression in PD. EU-approved for treatment.

Investment Opportunity

Join us in revolutionizing mental health access through strategic TMS clinic expansion. Bridge loan investors gain early access, preferred returns, and structured exit options.

Why Invest in Tranquil Health?

  • Immediate Capital Deployment

    Your investment goes directly into proven clinic operations with immediate revenue generation.

  • Proven Revenue Model

    $7,000+ average revenue per patient with 80%+ treatment response rates driving repeat business.

  • Early Access & 20% Returns

    Bridge investors get preferred access and potential 20% annual returns plus equity participation.

  • Expanding $280B+ Market

    Mental health market growing rapidly with increasing acceptance of innovative treatments like TMS.

Revenue & Return Model

Our structured return model provides multiple income streams and clear exit strategies for bridge investors, ensuring both immediate returns and long-term growth participation.

10 %

10% Fixed Annual Dividend

Guaranteed annual return on your bridge loan investment

10 %

10% Operations Dividend

Additional returns based on operational performance

100 %

Return of Capital

Full return of invested principal upon exit

10 %

Equity Share

10% share of sale proceeds beyond capital return

Experience the Difference

At Tranquil Health, we work by funding cutting-edge TMS technology with compassionate care through our operating partner’s modern, comfortable clinic environments designed with your wellbeing in mind.

Frequently Asked Questions

Here are some common questions we receive. Can’t find what you’re looking for? Send us a message above.

Is TMS FDA-Approved?

TMS is FDA-approved for Major Depressive Disorder (MDD), Obsessive-Compulsive
Disorder (OCD), and Smoking Cessation (nicotine dependence).

  1. CE-approved uses for TMS in Europe are often prescribed by our US
    clinicians who are trained in “off-label” TMS procedures such as:
    1. Parkinson’s Disease (motor symptoms, freezing of gait)
    2. Post-Traumatic Stress Disorder (PTSD)
    3. Autism Spectrum Disorder (ASD) / Asperger’s Disorder
    4. Alzheimer’s Disease
    5. Chronic Pain (neuropathic pain, fibromyalgia, interstitial cystitis)
    6. Multiple Sclerosis (fatigue)
    7. Stroke Rehabilitation (motor and speech recovery)
  2. Off-label prescribing is a normal and legal part of a medical practice. It
    allows doctors to use their judgment to extend treatments like TMS to
    areas where research shows potential benefit.

Yes. TMS is non-invasive and well-tolerated. The most common side effect is mild scalp discomfort or headache, usually improving over time.

80%+ patients experience significant improvement; 60%+ achieve complete remission of depression symptoms.

Because remission means your chronic symptoms of not feeling well are basically gone, not just improved. Patients who achieve remission thru TMS feel and function better in daily life, have a lower risk of relapse, and enjoy a higher quality of life than those with only partial improvement.

Adults with depression, OCD, and other chronic symptoms who have not found relief with medications or therapy.

Each daily session lasts approximately 20–30 minutes.

Not if you have ferromagnetic implants in or near the head (e.g., aneurysm clips, cochlear implants). Other devices are evaluated on a case-by-case basis.

Most commercial insurers and Medicare cover TMS for Major Depressive Disorder and OCD. Smoking cessation coverage is expanding.  In selected states, Medicaid will cover TMS treatments.

You start with an evaluation by our clinical team to confirm diagnosis, review prior treatments, and ensure safety before beginning a TMS course of treatment.

Ready to Invest?

Join us in transforming mental health access while securing attractive returns for your investment.